Table_7_The Association of HLA-G Gene Polymorphism and Its Soluble Form With Male Infertility.docx
Successful reproduction depends on many factors. Male factors contribute to infertility in approximately 50% of couples who fail to conceive. Seminal plasma consists of secretions from different accessory glands containing a mixture of various cytokines, chemokines, and growth factors, which together can induce a local immune response that might impact on a male’s as well as a female’s fertility. Human leukocyte antigen (HLA)-G expression has been suggested as an immunomodulatory molecule that influences pregnancy outcome. The HLA-G gene encodes either membrane-bound or/and soluble proteins. The aim of this study was the evaluation of HLA-G polymorphisms and their impact on soluble HLA-G (sHLA-G) production. We tested the HLA-G polymorphism in three positions: rs1632947: c.-964G>A; rs1233334: c.-725G>C/T in the promoter region; rs371194629: c.∗65_∗66insATTTGTTCATGCCT in the 3′ untranslated region. We tested two cohorts of men: 663 who participated in in vitro fertilization (test material was blood or sperm), and 320 fertile controls who possessed children born after natural conception (test material was blood). Since 50% of men visiting assisted reproductive clinics have abnormal semen parameters, we wondered if men with normal sperm parameters differ from those with abnormal parameters in terms of HLA-G polymorphism and secretion of sHLA-G into semen. We found that certain rs1632947-rs1233334-rs371194629 HLA-G haplotypes and diplotypes were associated with male infertility, while others were protective. Normozoospermic men with the A-C-del haplotype and A-C-del/A-C-del diplotype secreted the most sHLA-G into semen (574.1 IU/mL and 1047.0 IU/mL, respectively), while those with the G-C-ins haplotype and G-C-ins/G-C-ins diplotype – the least (80.8 IU/mL and 75.7 IU/mL, respectively). Men with the remaining haplotypes/diplotypes secreted sHLA-G at an intermediate level. However, only in one haplotype, namely G-C-ins, did we observe strong significant differences in the concentration of sHLA-G in the semen of men with teratozoospermia compared to men with normal sperm parameters (p = 0.009). In conclusion, fertile men differ in the profile of HLA-G polymorphism from men participating in IVF. Among all HLA-G haplotypes, the most unfavorable for male fertility is the G-C-ins haplotype, which determines the secretion of the lowest concentration of the soluble HLA-G molecule. This haplotype may reduce sperm parameters.
History
References
- https://doi.org//10.1016/j.fertnstert.2018.08.015
- https://doi.org//10.1093/biolre/ioz161
- https://doi.org//10.1016/j.clinbiochem.2018.03.012
- https://doi.org//10.1177/0960327117703690
- https://doi.org//10.18632/aging.102120
- https://doi.org//10.1016/j.fertnstert.2016.07.1101
- https://doi.org//10.1111/j.1600-0897.2011.01033.x
- https://doi.org//10.1016/j.jprot.2016.08.018
- https://doi.org//10.1016/j.jri.2015.02.001
- https://doi.org//10.1007/978-3-319-18881-2_8
- https://doi.org//10.1093/molehr/gar052
- https://doi.org//10.1111/aji.12251
- https://doi.org//10.1155/2014/591489
- https://doi.org//10.1111/aji.13152
- https://doi.org//10.1111/tan.13628
- https://doi.org//10.3389/fimmu.2019.02982
- https://doi.org//10.1016/j.bbrc.2003.11.153
- https://doi.org//10.1016/j.humimm.2005.12.003
- https://doi.org//10.1093/humupd/dmr043
- https://doi.org//10.1016/j.humimm.2003.08.347
- https://doi.org//10.1371/journal.pone.0071742
- https://doi.org//10.1155/2014/734068
- https://doi.org//10.3389/fimmu.2014.00476
- https://doi.org//10.1155/2014/734068
- https://doi.org//10.1093/hmg/ddi389
- https://doi.org//10.1086/375501
- https://doi.org//10.1093/humrep/del036
- https://doi.org//10.1007/s00438-017-1404-3
- https://doi.org//10.1073/pnas.93.1.161
- https://doi.org//10.4049/jimmunol.1001081
- https://doi.org//10.4049/jimmunol.175.12.8379
- https://doi.org//10.1002/1521-4141(200202)32%3A23.0.CO;2-8
- https://doi.org//10.1016/j.humimm.2016.09.002
- https://doi.org//10.1016/j.fertnstert.2020.04.052
- https://doi.org//10.1034/j.1399-0039.2001.057001015.x
- https://doi.org//10.1016/j.humimm.2016.06.020
- https://doi.org//10.1093/humupd/dmi048
- https://doi.org//10.3389/fimmu.2018.02164
- https://doi.org//10.3389/fimmu.2020.01178
- https://doi.org//10.3390/ijms21124307
- https://doi.org//10.1093/molehr/gav037
- https://doi.org//10.3389/fimmu.2014.00198
- https://doi.org//10.1016/j.jri.2019.102857
- https://doi.org//10.1007/s12094-019-02244-2
- https://doi.org//10.1371/journal.pone.0098284
- https://doi.org//10.1111/j.1399-0039.2011.01814.x
- https://doi.org//10.1016/j.semcancer.2012.03.003
- https://doi.org//10.1016/j.humimm.2012.11.016
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity